Приказ основних података о документу

dc.creatorMaksić, Jelena
dc.creatorJovanović, Marko
dc.creatorRakić, Tijana
dc.creatorPopović, Igor
dc.creatorIvanović, Darko
dc.creatorJančić-Stojanović, Biljana
dc.date.accessioned2019-09-02T11:44:43Z
dc.date.available2019-09-02T11:44:43Z
dc.date.issued2015
dc.identifier.issn0021-9665
dc.identifier.urihttps://farfar.pharmacy.bg.ac.rs/handle/123456789/2318
dc.description.abstractIn this paper, chromatographic analysis of active substance olopatadine hydrochloride, which is used in eye drops as antihistaminic agent, and its impurity E isomer by hydrophilic interaction liquid chromatography (HILIC) and application of design of experiments (DoE) methodology are presented. In addition, benzalkonium chloride is very often used as a preservative in eye drops. Therefore, the evaluation of its chromatographic behavior in HILIC was carried out as well. In order to estimate chromatographic behavior and set optimal chromatographic conditions, DoE methodology was applied. After the selection of important chromatographic factors, Box-Behnken design was utilized, and on the basis of the obtained models factor effects were examined. Then, multi-objective robust optimization is performed aiming to obtain chromatographic conditions that comply with several quality criteria simultaneously: adequate and robust separation of critical peak pair and maximum retention of the first eluting peak. The optimal conditions are identified by using grid point search methodology. The experimental verification confirmed the adequacy of the defined optimal conditions. Finally, under optimal chromatographic conditions, the method was validated and applicability of the proposed method was confirmed.en
dc.publisherOxford Univ Press Inc, Cary
dc.relationinfo:eu-repo/grantAgreement/MESTD/Basic Research (BR or ON)/172052/RS//
dc.rightsopenAccess
dc.sourceJournal of Chromatographic Science
dc.titleChromatographic Analysis of Olopatadine in Hydrophilic Interaction Liquid Chromatographyen
dc.typearticle
dc.rights.licenseARR
dcterms.abstractЈовановић, Марко; Ракић, Тијана; Поповић, Игор; Максић, Јелена; Ивановић, Дарко; Јанчић-Стојановић, Биљана;
dc.citation.volume53
dc.citation.issue5
dc.citation.spage680
dc.citation.epage686
dc.citation.other53(5): 680-686
dc.citation.rankM23
dc.identifier.wos000360833600005
dc.identifier.doi10.1093/chromsci/bmu102
dc.identifier.pmid25300592
dc.identifier.scopus2-s2.0-84941710230
dc.identifier.fulltexthttps://farfar.pharmacy.bg.ac.rs//bitstream/id/1030/2316.pdf
dc.type.versionpublishedVersion


Документи

Thumbnail

Овај документ се појављује у следећим колекцијама

Приказ основних података о документу